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BACKGROUND: HIV/AIDS predisposes to malnutrition. Malnutrition exacerbates HIV/AIDS 
progression resulting in increased morbidity and mortality. The magnitude of malnutrition in HIV/AIDS 
patients has not been well studied in Ethiopian setup. Our objective was to assess the prevalence of 
malnutrition and associated factors among HIV/AIDS patients admitted to Jimma University Specialized 
Hospital (JUSH). 
METHOD: A cross-sectional study was conducted to assess the nutritional status of 109 HIV/AIDS 
patients admitted from November 2013 to July 2014. Cohort design was also used for outcome 
assessment. Serum levels of hemoglobin, albumin and CD4 counts were determined. Data were 
organized, coded, cleaned, entered into a computer and analyzed using SPSS version 16.0.  Descriptive 
analysis was done initially. Those variables in the bivariate analysis with P–value < 0.25 were then 
considered as candidates to be included in the multivariable logistic regression model. A P-vale of < 0.05 
was considered as statistically significant.  
RESULTS: The mean age of the patients was 32.7+8.12 with male to female ratio of 1:1.9. Patients were 
in either clinical stage, 3(46.8%), or stage, 4(53.2%). Forty nine (45%) of the respondents had a CD4 
count of < 200 cells/µL. The overall prevalence of malnutrition was 46.8% (BMI<18.5kg/m2) and 44.1% 
(MUAC≤ 20cm). Eighty four (77.1%) of the patients had a serum albumin level of ≤3.5g/dl while 76 
(69.6%) of the patients had anemia (Hg<12g/dl).   
CONCLUSION: The prevalence of malnutrition was found to be high. WHO Stage 4 disease and CD4 
count <200cells/µl were independent predictors of malnutrition.  




   
Malnutrition is defined as the cellular imbalance 
between supply of nutrients and energy and the 
body’s demand for them to ensure growth, 
maintenance and specific functions (1,2). 
Nutrition and HIV are strongly related and 
complement each other. Both can independently 
cause progressive damage to the immune system. 
Malnutrition is a frequent problem in persons 
infected with HIV. It adds fuel to the fire by 
accelerating the progress of HIV infection to 
AIDS. HIV/AIDS is also associated with 
biological and social factors that affect the 
individual’s ability to consume, utilize and acquire 
food (1,3). 
Causes of malnutrition in patients with AIDS 
may be multi-factorial. It includes disorders of 
food intake, opportunistic infections, diarrhea, 
nutrient malabsorption and wasting syndrome 
(3,4,5,6). Furthermore, HIV specifically affects 
nutritional status by increasing energy 
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and oxidative stress (5,6,7). HIV/AIDS patients 
require 10% more energy when asymptomatic and 
20–30% more when symptomatic compared to 
uninfected individuals (4).  
The world's highest HIV infection rates are 
found in Sub-Saharan Africa (SSA). Food 
shortages and malnutrition have combined with 
HIV/AIDS to bring some countries to the brink of 
crisis (8,9).  Malnutrition and food insecurity are 
associated with increased mortality and poor 
clinical outcomes among people living with 
HIV/AIDS (10). The HIV/AIDS epidemic has had 
security and overall socioeconomic development 
in countries that have been greatly affected by the 
disease (11). 
Attention to the problems of malnutrition in 
patients with AIDS is of paramount importance 
because the timing of death in these patients may 
be more closely related to the degree of body cell 
mass depletion than to any specific underlying 
infection [3]. The nutritional problems have been 
shown to be significant and contribute to 
morbidity and mortality in HIV+/AIDS patients 
(8). Evidence indicates that even relatively small 
losses in weight (5%) are associated with 
decreased survival rate (12). There is an urgent 
need for renewed focus on and use of resources 
for nutrition as a fundamental part of the 
comprehensive package of care at country level (7, 
11). 
It has been postulated that the use of HAART 
would reduce the occurrence of HIV associated 
weight loss and wasting (13). Commencement of 
HAART in HIV infected individuals exhibits 
benefits to the circulating serum albumin levels 
(14).  
Malabsorption resulting from intestinal 
problems leads to subtherapeutic levels of ARV 
drugs and treatment failure. Thus, patients with 
malabsorption could require dose adjustment 
and/or dietary supplements during periods of 
diarrheal illness (5).  
Malnutrition at the time of starting ART was 
significantly associated with decreased survival 
(12,15,16). Low BMI at ART initiation was 
associated with poor treatment outcomes. 
Conversely, normal BMI was associated with 
adequate CD4 response and reduced lost to follow 
up cases (17). BMI at diagnosis is a strong, 
independent predictor of survival in HIV-infected 
patients in West Africa. In the absence of 
sophisticated clinical and laboratory support, BMI 
may also prove a useful guide for deciding when 
to initiate antiretroviral therapy (10,18).  
Unemployment, WHO clinical AIDS stage 
four, one or more number of previous 
opportunistic infections and gastrointestinal 
symptoms were found to be important risk factors 
for malnutrition among people living with 
HIV/AIDS (6). Tuberculosis, central nervous 
system toxoplasmosis and sepsis were the three 
most common disease complexes among 
admissions and deaths (19). 
Anemia is the most common hematologic 
abnormality in HIV patients. Anemia is a predictor 
of progression from HIV infection to AIDS or 
death; more than 70% of HIV patients develop 
anemia and thus require blood transfusion (20).  
Anemia, thrombocytopenia and severe 
malnutrition were strong independent predictors of 
mortality (16). 
Literatures on the prevalence and factors 
associated with malnutrition among people living 
with HIV/AIDS are limited in Ethiopia and not 
well documented either (6). Only few studies were 
done on malnutrition and HIV/AIDS in Ethiopia 
(6,7,19,20). There are no such studies done in 
hospitalized HIV/AIDS patients in Jimma. 
Therefore, the aim of this study was to assess the 
prevalence of malnutrition and associated factors 
in HIV/AIDS patients who were admitted to 
medical wards of our hospital during the study 
period. The outcome of this study is expected to 
encourage healthcare providers to strengthen the 
quality of nutritional assessment and care.  It can 
also serve as a baseline for further large scale 
studies on nutrition and HIV/AIDS. 
 
METHODS AND PATIENTS 
 
The study was done on HIV/AIDS patients 
hospitalized to Jimma University Specialized 
Hospital located in Jimma Town, Southwest 
Ethiopia. The hospital serves as a teaching and 
referral hospital with a catchment of 15 million 
people. The hospital has three medical wards with 
85 admission beds. It also has a chronic care and 
training centre for HIV/AIDS and TB patients.  
A hospital based prospective cross-sectional study 
design was used to study all adult (> 18 yrs of age) 
HIV/AIDS patients admitted to medical wards 
from November 10, 2013 to July 10, 2014. We 
also used cohort design to assess our secondary 




objective, i.e. the outcome of patients with 
malnutrition at the end of discharge or at the end 
of the study. The required sample size was 
calculated using single population proportion 
formula, assuming the prevalence of malnutrition 
among HIV/AIDS patients to be 50%. It was 
calculated to be 384. From the hospital record, the 
total number of HIV/AIDS patients admitted to 
medical wards in the preceding year was 161. 
Applying a formula for finite population 
correction, the final required sample size to 
conduct the study was 114. To get the required 
sample size, we used convenience sampling. 
Therefore, All HIV/AIDS patients admitted to 
JUSH medical wards over the study period were 
included in the study. Patients with cognitive 
impairment and those who required immediate 
intensive care support were excluded.  
Accordingly, out of 114 admitted HIV/AIDS 
patients who were admitted during the study 
period, 109 patients who fulfilled the inclusion 
criteria were included in the study.   
Data were collected by trained medical 
residents working in medical wards during the 
study period. Ethical clearance was obtained from 
the Ethical Review Board of the College of Public 
Health and Medical Sciences, Jimma University 
College. The medical director, ward physicians 
and nurses were contacted before starting data 
collection. The aim of the study was explained to 
the study participants. They understood that it has 
no any harm on them. No one was deprived of any 
medical treatment and all malnourished 
individuals were treated in accordance with the 
protocol of the hospital. To maintain 
confidentiality of the study participants, any 
personally identifiable information (e.g. name, 
address) was not recorded on the data collection 
format.  
A structured questionnaire was used to gather 
sociodemographic information, and relevant 
clinical history was collected by interviewing 
patients using a structured questionnaire. Main 
variables of interest were time since HIV 
diagnosis, prior HIV related hospitalizations, 
medical conditions related to current 
hospitalization, duration of hospital stay, HAART 
status,  history of drug interruption [adherence] 
and patient response to therapy [outcome]. 
Adherence to HAART was defined as regular use 
of ARVs at the right frequency of dosing and 
timing. Ability to keep to this pattern of utilization 
was defined as 100% adherence, while adherence 
of >95% was accepted as optimal adherence. 
Levels of adherence below 95% were considered 
to be sub-optimal.  
Nutritional status was assessed using Body 
Mass Index [BMI], Mid Upper Arm 
Circumference (MUAC), serum Albumin and 
serum Hemoglobin levels. Patients with 
BMI<18.5kg/m2, MUAC < 20cm or serum 
albumin<3.5g/dl were categorized as 
malnourished (3,4,14,18). Patients were 
systematically evaluated for presence of 
opportunistic diseases and co-morbid illnesses 
which were further supplemented with the data 
obtained through patient interview and chart 
review. CD4 count was determined at the time of 
admission. Clinical outcome [i.e. patients’ clinical 
status or response to therapy] was assessed at the 
end of the study period or in-between if an event 
like discharge, ICU transfer, or death occurred. 
The occurrence of death, prolonged hospitalization  
[> 14 days], need of ICU admission were 
considered as unfavorable outcomes. 
Anthropometric and laboratory measurements 
were done in a standard way. Weight was 
measured with a weight scale and height was 
measured with a height scale after daily 
calibration before starting data collection. The 
mean of three measurements of each of the 
anthropometric measurements were taken and 
reported as the final measurement. For laboratory 
assessments of nutritional status, blood tests for 
serum albumin and hemoglobin were performed 
by an experienced laboratory technologist. A 5 ml 
blood sample was taken from the cubital fossa, 2.5 
ml was put in an EDTA tube for complete blood 
count and 2.5 ml was put in a tube with no 
anticoagulants for serum albumin determination. 
Serum albumin was determined by HORIBA 
medical™ ABX Pentra 400 with the use of 
appropriate human serum controls. Complete 
blood count determination was done using 
Cysmex KX21 machine. All results were 
expressed to the nearest 0.1 decimal place. The 
data collection instrument was pre-tested on 5% of 
the total sample size before actual data collection. 
The process of data collection was daily 
supervised and monitored by the principal 
investigator. The completeness and consistency of 
data is checked before compilation. The compiled 





data were organized, cleaned, coded, entered into 
a computer and analyzed using SPSS version 16.0. 
First, descriptive analysis was done. Then, 
bivariate analysis was done to identify factors 
associated with nutritional status. Those variables 
with P–value < 0.25 in the bivariate analysis were 
considered as candidates to be included in the 
multivariable logistic regression model. A P-vale 




Socio-demographic characteristics: A total 
of 114 HIV/AIDS patients were admitted to 
medical wards during the study period. One 
hundred and nine of them fulfilled the inclusion 
criteria and included in the analysis. Two patients 
with cognitive impairment, another two patients 
who were directly admitted to ICU, and one 
patient who refused to be included in the study 
were excluded from the study. This resulted in a 
response rate of 95.6%. 
Seventy-two (66.1%) of the patients were females. 
The mean age of the study subjects was 
32.7+8.12. Fifty (45.9%) of them were in the age 
group of 25-34 years. Only 20(18.5%) of the 
respondents had completed college level 
education. Thirty-four (31.2%) were farmers. The 
majority of the study subjects, 68(62.2%), were 
urban residents. The majority of the patients, 
83(76.1%), had poor socioeconomic status with 
annual income of < 1700 Birr, and the mean 
monthly income was 978 Birr with the majority 




 quartiles (Table 1). 
a devastating impact on health, nutrition, food  
 
Table 1: Socio-demographic characteristics of HIV/AIDS patients admitted to JUSH from November 2013 





Category  Frequency Percent 
Age  
 
<24 11 10.1 
25-34 50 45.9 
35-44 37 33.9 
>45 11 10.1 
Sex Male  37 33.9 
Female  72 66.1 
Educational status Illiterate 39 35.8 
Primary education 30 27.5 
Secondary education 20 18.5 
College and above 20 18.5 
Occupation Government employee  28 25.5 
Merchant  11 10.1 
Farmer  34 31.2 
Student  6 5.5 
unemployed  30 27.5 
Monthly income 
(in Birr) 
<193 27 24.8 
193-420  28 25.7 
421-1700 28 25.7 
>1700 26 23.9 
Residence  Urban 68 62.4 
Rural 41 37.6 
 
Clinical characteristics: Seventy five (68.8%) 
of the study subjects were known HIV/AIDS 
patients already on chronic care and follow-up. Of 
these, 64(85%) were on HAART. Fifteen (23.4%) 
of the patients taking HAART had sub-optimal 
(<95%) adherence. All of the patients admitted 
were in either WHO clinical stage III, 51(46.8%) 
and stage IV, 58(53.2%). The average current 




CD4 count was 247.7+165 cells/liter, and 49(45%) 
of the respondents had a CD4 count of less than 
200 cells/liter. The major medical conditions 
associated with the current hospitalization were 
tuberculosis (both pulmonary and disseminated 
TB), 36(33%), bacterial pneumonia, 24(22%), 
severe anemia, 24(22%), and oro-esophageal 
candidiasis 18(16.5%). The average hospital stay 
was 19.3+10.6 days and 69(63.3%) of the patients 
were hospitalized for more than 14 days. Patients 
with malnutrition stayed for 22.7 days on average, 
while those without malnutrition stayed for 16.3 
days. A large proportion of patients with 
malnutrition (80.3%, n=41) had greater than 14 
days of hospital stay as compared to those who are 
not malnourished (48.3%, n=28). Most, 
70(64.2%), of the patients were discharged 
improved, while 23(21.1%) of them died (Table 
2). 
 
Table 2: Clinical characteristics of HIV/AIDS patients admitted to JUSH from November 2013 to July 2014 
 
 
Clinical Characteristics Category  Frequency Percentage 
























CNS Toxoplasmosis  
Cryptococcal meningitis 
Chronic diarrhea 
GI onset sepsis 
CLD, chronic viral 
hepatitis 
Others* 



























































*NHL, acute viral hepatitis, IRIS, brain abcess, Kaposi sarcoma, splenic abcess, ESRD 
 
 
Nutritional status: The average BMI and MUAC 
was 19.0+3.39 and 21.5+3.75, respectively. Fifty-
one (46.8%) and 46(42.2%) of the patients were 
malnourished using BMI < 18.5kg/m2 and MUAC 
< 20cm, respectively. The mean serum albumin 
was 2.87 + 0.73. Eighty-four (77.1%) of the 
patients had a serum albumin of less than 
3.5g/liter. The mean hemoglobin was 9.7+3. 
Seventy-six (69.6%) of the patients were anemic 
(Hg < 12g/dl), and 19 (17.7%) of them had severe 
anemia (Table 3).  





Table 3: Nutritional status of HIV/AIDS patients 





Category  Frequency  Percent 
Body mass 
index 
<18.5 51 46.8 
>18.5 58 53.2 
MUAC <20 46 42.2 
>20 63 57.8 
Albumin 
 
<3.5 84 77.1 
>3.5 25 22.9 
Hemoglobin <7 27 24.8 
7-9.9 30 27.5 
10-11.9 19 17.4 
>12 33 30.3 
 
Factors associated with malnutrition: Among 
the socio-demographic variables, only female sex 
and being farmer were found to have statistical 
association with malnutrition (Table 4).  
The clinical variables significantly associated 
with malnutrition were longer duration (> 2years) 
since HIV diagnosis, having two or more 
opportunistic diseases/co-morbidities, longer 
duration (>14 days) of hospital stay, not being on 
HAART, suboptimal adherence to HAART, 
advanced clinical stage and in-hospital mortality. 
Similarly, CD4 count < 200 cell/µl, serum 
albumin <3.5 gm/dl and serum hemoglobin < 
7gm/dl were found to be significantly associated 
with malnutrition (Table 5).  
Table 4: Association of socio-demographic variables with nutritional status in HIV/AIDS patients admitted 
to JUSH, from November 2013 to July 2014. 
 
Variables  Category  Nutritional status  
P- value BMI>18.5 BMI<18.5 
Sex Male 20 17 0.016 
0.899 Female  38 34 
Age group <24 5 6 1.863 
0.601 25-34 28 22 
35-44 21 16 
 >44 4 7 
Marital status Single  9 12 3.099 
0.377 Married 28 18 
Divorced 9 6 
Widowed 12 15 
Residency  Urban 40 28 2.287 
0.130 Rural  18 23 
Educational   
status 
Illiterate 19 20 7.340 
0.62 Primary  13 17 
Secondary 10 10 
College& above 16 4 
Occupation  Government employee 22 6 13.258 
0.021 Merchant 4 7 
Student 3 3 
Farmer 16 18 
Unemployed 13 17 
Income (in birr) <193birr/month 12 15 4.143 
0.246 193-420birr/month 12 16 
421-1700birr/month 18 10 
>1700birr/month 16 10 




Table 5: Association clinical and laboratory variables with nutritional status in HIV/AIDS patients admitted 







Nutritional status  
P- value BMI>18.5 BMI<18.5 
Time of HIV diagnosis New 12 22 6.384 
0.041 
 
<2years 20 13 
>2years 26 16 
2 or more co-morbidities Yes 9 31 23.938 
0.001 No 49 20 
WHO Clinical stage Stage 3 40 11 24.486 
0.000 Stage 4 18 40 
HAART Yes 40 24 5.373 
0.020 No 18 27 
HAART Adherence Optimal  34 15 4.232 
0.040 Sub-optimal 6 9 
Prior HIV related admission Yes  19 17 2.137 
0.144 No  27 12 
CD4 count at admission <200 18 31 9.706 
0.002 ≥200 40 20 
Mortality  
 
Yes 8 15 3.976 
0.046 No 50 36 
Hospital stay <14days 30 10 12.049 
0.001 >14days 28 41 
Serum albumin 
 
<3.5 35 49 19.605 
0.001  >3.5 23 2 
Hemoglobin <7 9 18 17.009 
0.001 7-9.9 11 19 
10-11.9 12 7 
>12 26 7 
 
 
However, multiple logistic regression analysis 
showed that only advanced clinical disease and 
lower CD4 count were independent predictors of 
malnutrition. Patients with stage 4 disease had 
14.5 times more likelihood of being malnourished 
(95% CI 3.621, 58.297). Similarly, the likelihood 
of malnutrition in patients with baseline CD4 
count < 200 cells/µ liter was 5.7 times more than 
















Table 6: Multiple logistic regressions of clinical stage and baseline CD4 count with nutritional status of 
HIV/AIDS patients admitted to JUSH, from November 2013 to July 2014. 
 
 




Stage 3 40 11  
.000 
1 
Stage 4 18 40 14.529(3.621,58.297) 
   CD4 
count at 
admission 
<200 18 31  
.022 
5.713(1.286,25.375) 
>200 40 20 1 
Constant    .000 .045 
 
DISCUSSION   
 
A total of 109 HIV/AIDS patients were included 
in the analysis. Fifty (45.9%) of the study subjects 
were in the age group of 25-34 years, which is the 
most affected age group by HIV according to 
Ethiopian Demographic and Health survey [DHS] 
2011report. This is also in line with findings from 
other studies in similar setups (4,6,19). 
The overall prevalence of malnutrition was found 
to be high. This is comparable with the rate of 
malnutrition in hospitalized AIDS patients in 
similar setups (6,16,17,19,20). This is because 
most of the admitted AIDS patients had advanced 
disease stage with CD4 counts < 200/µL which is 
known to be related with malnutrition. The higher 
rate of concomitant opportunistic diseases like 
tuberculosis in such patients could also contribute 
to the high prevalence of malnutrition. Similarly, 
most of our patients  were also found to be 
anemic. This can be justified by the advanced 
stage of the disease, high prevalence of 
malnutrition, low socioeconomic status, high 
occurrence of co-morbidities and drug side effects 
(3, 6, 7, 10, 16, 19). 
All of the patients admitted were either WHO 
clinical stage III or stage IV. Thirty nine (35.8%) 
of our patients had unfavorable outcome with 
overall mortality of 21.1%. The major medical 
condition associated with current hospitalization 
was tuberculosis (33%) followed by pneumonia 
(22%) and anemia (22%). Having two or more co-
morbid medical conditions at admission had a 
significant association with malnutrition (p 
value=0.001). Similarly, long duration of hospital 
stay and in-hospital death were statistically 
associated with malnutrition (p value=0.019; p 
value=0.007, respectively). This is also in line 
with the commonest causes of HIV/AIDS related 
admissions and mortality worldwide 
(6,7,9,10,12,16,17, 18,19).  Patients with clinical 
stage 4 disease were found to have more than 14 
times higher likely hood of being malnourished 
compared to those with clinical stage 3 disease 
(AOR=14.529; 95.0% CI=3.621,58.297). This is 
also comparable with other studies which showed 
similar results (3, 6, 7, 12, 15, 16, 19).  
Most of the patients were hospitalized for 14 
or more days. The length of hospital stay had a 
statistically significant association with nutritional 
status (P=0.001). The average hospital stay was 
19.3+10.6 days. This is a shorter duration 
compared to the mean length of hospital stay (27.5 
days) found by a similar study done in a national 
referral hospital (19). Since the later study was 
conducted in a national referral hospital, there is 
increased chance of admitted patients being more 
complicated and critical who are referred from all 
regions of the country. Moreover, it was 
conducted in 2003 before the wide spread use of 
HAART which is important for favourable 
treatment outcome and shorter hospital stay. On 
the other hand, the duration of hospital stay in our 
study is longer than the average HIV-related 
hospital stays in Australia (14 days) and in USA 
(6.9 days). This could be due to the fact that the 
studies were done at different setups and level of 
standards of care. The higher rate of malnutrition 
could also contribute to the prolonged hospital 
stay in our study. Other similar studies done in 
Ethiopian setup did not analyze the length of 
hospital stay (6,7,20). 
Similarly, patients with CD4 count below 200 
cells/µliter had more than fivefolds chance of  
being malnourished compared to those with CD4 
count >200cells/µliter (AOR=5.713; 95.0% 
CI=1.286, 25.375). Similar studies done in 
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Ethiopian setup (6,7,20) showed similar  
association between CD4 count and nutritional 
status . The finding also goes with similar studies 
done in other developing countries (4,16,17).  
Even a study done in developed countries showed 
statistically significant association of lower CD4 
count (<100cells/μl) with malnutrition (14).  
In conclusion, most of our patients were 
younger with male to female ratio of 1:1.9. The 
majority of them were also found to have poor 
socioeconomic status and advanced stage of AIDS 
with high rate of opportunistic diseases and/or co 
morbidities. As a result, most of them also had 
longer (≥ 14 days) hospital stay with unfavorable 
outcomes.  
The overall prevalence of malnutrition was 
found to be high. WHO clinical stage 4 diseases 
and CD4 count <200/µL were independently 
associated with malnutrition. We recommend 
comprehensive nutritional assessment and care 
with special emphasis on patients with CD4 count 
of less than 200/µL and/or those with advanced 
stages of the disease as part of their HAART care. 
We also recommend that large scale prospective 
cohort study be conducted including all 
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